Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Hillman Solutions Corp. reported record Q3 2026 net sales of $457.5 million, a 7.7% increase year-over-year, driven by growth in its Robotics and Digital Solutions segment. The company updated its full-year 2026 net sales guidance to $1.660-$1.680 billion while reaffirming its Adjusted EBITDA target of approximately $285 million. During the quarter, Hillman also completed the acquisition of Kanebridge and refinanced its credit facilities.
Term
Q3 2026
“The third quarter reflects the continued execution of Hillman’s Blueprint for Strategic Growth. We continue to deliver net sales growth and strong free cash flow generation that give us the flexibility to invest into attractive opportunities, like our high-margin Robotics and Digital Solutions segment - which had a great quarter, up 19.2% - and accretive acquisitions, like Kanebridge.”
Jon Michael Adinolfi, CEO
“Given our performance through the first nine months, we are reaffirming our full-year Adjusted EBITDA and free cash flow guidance while narrowing down our net sales range, given the macro environment. As we look to the rest of 2026 and beyond, we are well positioned to drive growth and create long-term value for our shareholders.”
Riverview Bancorp Director Jon Louis Girod Buys $12.1K of Stock
Jon Louis Girod, Director, bought 2,000 shares of Riverview Bancorp Inc at $6.04 a share, worth $12.1K in total on Oct 30, 2026. Shares held after the trade: 5,000 (+66.7%).
Federal Realty Investment Trust filed a prospectus supplement to register the resale of up to 3,901,260 common shares by selling stockholders. These shares are potentially issuable upon the exchange of $460 million in 3.500% Exchangeable Senior Notes due 2031 previously issued in August 2026.
Cooper-Standard Holdings Inc. adopted a Section 382 Rights Agreement (poison pill) to protect approximately $215 million in U.S. net operating loss carryforwards and other tax benefits. The plan deters any person or group from acquiring 4.9% or more of the company's common stock, which could trigger an 'ownership change' and limit the use of these tax assets. The rights will be distributed to stockholders of record on November 12, 2026, and are set to expire in November 2029 unless ratified by stockholders at the 2027 annual meeting.
Crescent Energy reported third quarter 2026 financial results, highlighted by production of 328 MBoe/d and $367 million in levered free cash flow. The company also announced an increased Permian synergy target of over $300 million and highlighted its pending $3.85 billion acquisition of Eagle Ford assets from Devon Energy.
“Our market-leading operational execution continues to drive strong results and differentiated value creation. We delivered higher production, lower capital and higher free cash flow than market expectations this quarter. We have assembled an exceptional asset base, anchored by a world-class Eagle Ford position, alongside significant opportunities across the Permian, Uinta and Crescent Royalties. Importantly, the next phase of Crescent’s value creation is largely within our control. Our focus is on execution.”
LXP Industrial Trust completed its merger with affiliates of Brookfield Asset Management and CPP Investments, resulting in LXP becoming a privately held company. The all-cash transaction valued LXP at approximately $5.2 billion, with common shareholders receiving $61.20 per share in cash.
Value
$5.2B
Counterparty
Brookfield Asset Management and Canada Pension Plan Investment Board
“This acquisition reflects our conviction in the long-term fundamentals of the U.S. industrial sector. We are acquiring a portfolio of modern logistics assets at an attractive basis in markets benefiting from strong demand for large-scale distribution facilities with limited supply. Combined with durable in-place cash flows, embedded rental growth and our operating expertise, these dynamics create a compelling opportunity to drive value for our investors.”
Lowell Baron, Chief Executive Officer of Brookfield Real Estate
“The acquisition of LXP adds a high-quality, scaled portfolio of modern logistics properties to our diversified portfolio of U.S. real estate investments. With strong occupancy and exposure to key distribution markets, we believe LXP is well positioned to capture further value as logistics markets evolve, supporting attractive long-term returns for the CPP Fund.”
Sophie van Oosterom, Managing Director, Head of Real Estate at CPP Investments
Hudson Technologies Insider Hartree Partners LP Buys $1.31M of Stock
Hartree Partners LP bought 300,000 shares of Hudson Technologies Inc at $4.25 to $4.44 a share (average $4.38) in 3 transactions, worth $1.31M in total between Oct 29, 2026 and Nov 2, 2026. Shares held after the trade: 5,648,517 (+0.7%).
Audioeye Director James B. Hawkins Buys $52.6K of Stock
James B. Hawkins, Director, bought 4,000 shares of Audioeye Inc at $13.15 a share, worth $52.6K in total on Oct 30, 2026. Shares held after the trade: 225,684 (+1.8%).
Diversified Healthcare Trust announced its third quarter 2026 financial results and provided updated full-year 2026 guidance. As of September 30, 2026, the company's $6.3 billion portfolio included 285 properties across 33 states, primarily focused on senior housing, medical office, and life science assets.
Patterson-UTI Energy reported total operating revenues of $1.34 billion for the third quarter of 2026, up from $1.18 billion in the prior year period. The company achieved a net income of $28.4 million for the quarter, a significant improvement from the $36.4 million net loss reported in Q3 2025, driven by higher revenues in Completion Services and Drilling Services.
GMEX Robotics Corp reported a 3.2% increase in revenue to $2.73 million for the six months ended December 31, 2025, but net loss widened significantly to $7.05 million from $1.68 million in the prior year. The increased loss was primarily driven by a $4.65 million unrealized loss on digital assets and a 410.7% surge in consulting fees related to capital raises and crypto investment strategies.
Goldman Sachs reported net earnings of $17.55 billion for the nine months ended September 30, 2026, a significant increase from $12.56 billion in the prior year period. Total net revenues grew to $56.24 billion, driven by strong performance in market making and investment banking, while total assets expanded to $2.18 trillion.
HealthStream reported Q3 2026 revenue of $83.3 million, an 8.9% increase year-over-year, though net income declined 11.7% to $5.4 million due to higher operating expenses and cybersecurity-related costs. The company also declared a quarterly cash dividend of $0.035 per share and updated its full-year 2026 financial guidance.
As of September 30, 2026, Acadia Realty Trust reported total assets of $4.83 billion and total equity of $2.68 billion. The company significantly reduced its mortgage and other notes payable from $893.9 million to $479.4 million during the first nine months of 2026, while increasing its unsecured notes payable and line of credit usage.
Tennant Company reported record third-quarter net sales of $322.3 million, a 6.2% increase year-over-year driven by volume growth in North America and a 71% surge in robotics sales. Net income rose 30.9% to $19.5 million, while the company reaffirmed its full-year 2026 guidance despite inflationary pressures and parts shortages.
Term
Q3 2026
“Our third quarter performance demonstrated strong momentum across the business, with orders up 9.5% and record third-quarter net sales, up 6%. Robotics continues to deliver, with revenue up 71% in the quarter and year-to-date robotics sales already exceeding full-year 2025. Gross margin recovery progressed ahead of expectations and our North America ERP operations continued to improve, though parts shortages continued to impact shipments, contributing to a $118 million backlog exiting the quarter.”
Dave Huml, Tennant President and Chief Executive Officer
United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.7M of Stock
Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $594.92 to $608.05 a share (average $600.09) in 13 transactions, worth $5.7M in total on Oct 30, 2026. Shares held after the trade: 324,443 (-0.0%).
Recursion Pharmaceuticals reported a net loss of $119.0 million for the third quarter of 2026, an improvement from the $162.3 million loss in the prior year period. Total revenue increased significantly to $18.6 million for the quarter, while the company maintained a strong liquidity position with $549.9 million in cash and cash equivalents as of September 30, 2026.
Chemours reported third quarter 2026 net sales of $1.5 billion, driven by a 10% pricing increase in Titanium Technologies and 26% growth in APM Performance Solutions. The company achieved net income of $196 million, significantly up from $46 million in the prior-year quarter, while also completing the sale of its Kuan Yin property for approximately $340 million.
“Our third-quarter results demonstrate strong year-over-year performance in TT and APM, reflecting pricing execution in TiO2 and increased demand across Performance Solutions’ high-value AI infrastructure including data center and semiconductor end markets.”
Denise Dignam, Chemours President and CEO
“We also continued to make meaningful progress under our Pathway to Thrive, including reaching a settlement with the State of North Carolina, driving operational improvements through the Chemours Business System, and closing the sale of the final parcel of land associated with our former Kuan Yin property.”
Select Water Solutions Signs $700M M&A Deal with Pilot Water Solutions LLC
Select Water Solutions completed its acquisition of Pilot Water Solutions LLC for approximately $700 million, consisting of $600 million in cash and 5,149,331 shares of Class A common stock. The deal enhances Select's water midstream position in the Delaware Basin and includes potential contingent payments based on operational milestones and stock price performance. In connection with the closing, the company also terminated its previous sustainability-linked credit facility and activated a new $500 million revolving credit facility.
Value
$700M
Counterparty
Pilot Water Solutions LLC
“The addition of Pilot Water enhances our position as one of the leading water midstream providers in the Delaware Basin, and further strengthens Select’s unique ability to manage the industry’s growing produced water volumes with comprehensive solutions. Pilot Water’s sizable contractual revenue, minimum volume commitments, and its significant operational and undeveloped capacity, complements Select’s extensive acreage dedications and enables future growth and produced water volume capture.”
John Schmitz, Chairman of the Board, President and CEO
The Procter & Gamble Company closed an underwritten public offering of $352.231 million in aggregate principal amount of Floating Rate Notes. The notes are due to mature on November 2, 2076, representing a long-term debt financing arrangement.
Recursion Pharmaceuticals reported Q3 2026 financial results, highlighting clinical data for REC-4881 and REC-1245 and the appointment of Fred Hassan as Chair of the Board. The company extended its cash runway into 2029 following an October follow-on offering and noted that Sanofi has optioned the first development candidate from their collaboration.
Term
Q3 2026
“To pioneer a new blueprint for making medicines with AI, we believe you have to tie together three core capabilities in one engine: uncover novel biology, design differentiated molecules against challenging targets, and generate clinical evidence that matters for patients.”
Najat Khan, Ph.D., President and Chief Executive Officer of Recursion
Capital Southwest reported a net increase in net assets from operations of $46.2 million for the six months ended September 30, 2026, compared to $52.6 million in the prior year period. Total investment income grew to $128.2 million from $112.9 million, while the company expanded its investment portfolio to $2.4 billion at fair value.
Telos Corporation has appointed Mark D. Griffin as President and Chief Executive Officer, effective November 2, 2026. He succeeds John B. Wood, who has served as CEO since 1994 and will now transition to the role of Executive Chairman. Mr. Griffin, a 40-year veteran of the company, most recently served as Executive Vice President of Security Solutions.
Avita Medical Debt Financing Update with Perceptive Credit Holdings V, LP
AVITA Medical disclosed that Perceptive Credit Holdings V, LP exercised a warrant for 500,000 shares of common stock via a cashless exercise. The warrant was originally issued in connection with a January 2026 Credit Agreement and Guaranty. After withholding 112,284 shares for the exercise price, the company issued 387,716 shares to Perceptive on October 28, 2026.
For the nine months ended September 30, 2026, Inspire Medical Systems reported a net loss of $35.4 million on revenue of $611.9 million, compared to a net profit of $9.3 million in the prior year period. The shift to a loss was driven by a decrease in revenue and a significant increase in selling, general, and administrative expenses.
Upwork reported a decrease in revenue to $185.6 million for the third quarter of 2026 compared to $201.7 million in the prior year. Despite lower revenue, net income increased to $31.8 million for the quarter, driven by a significant reduction in operating expenses, particularly in research and development and sales and marketing.
ProPetro Holding CFO Caleb Lyle Weatherl Buys $15.6K of Stock
Caleb Lyle Weatherl, CFO, bought 2,000 shares of ProPetro Holding Corp. at $7.78 a share, worth $15.6K in total on Oct 30, 2026. Shares held after the trade: 29,338 (+7.3%).
UGI $700M Debt Financing with JPMorgan Chase Bank, N.A.
UGI Corporation entered into a second amendment to its credit agreement, increasing its existing revolving credit facility from $475 million to $700 million and extending the maturity date to March 31, 2030. The amendment also establishes a new $300 million senior secured revolving loan facility specifically to finance cash considerations for the conversion of its 2028 Notes. The new facility is secured by equity pledges in certain material subsidiaries and carries a floating interest rate based on Term SOFR or an Alternate Base Rate.
Axsome Therapeutics reported total revenues of $259.7 million for the third quarter of 2026, driven primarily by product sales of AUVELITY, SUNOSI, and SYMBRAVO. While the company remains in a net loss position of $12.9 million for the quarter, this represents a significant improvement from the $47.2 million loss in the prior year period as commercial scale increases.
Three directors, including Board Chair Dr. Jiong Ma, resigned from the Board of Anavex Life Sciences Corp. effective October 28, 2026. The resignations of Dr. Ma, Mr. Gautam Patel, and Dr. Adrian Senderowicz were due to disagreements regarding the company's strategic direction and business plan execution. The company subsequently reconstituted its Audit, Compensation, and Nominating committees on November 1, 2026.